NASDAQ · WALD
Technology · Software - Application
$1.31
Down-$0.02 (-1.50%)
Updated Sep 13, 2026, 2:46 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
WALD closed at $1.31 after 19 trading sessions, down 3.68% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.36 | $1.36 | $1.30 | $1.31 | 39.05K |
| Sep 10, 2026 | $1.31 | $1.36 | $1.305 | $1.33 | 76.4K |
| Sep 9, 2026 | $1.33 | $1.375 | $1.305 | $1.33 | 130.13K |
| Sep 8, 2026 | $1.36 | $1.38 | $1.28 | $1.29 | 128.2K |
| Sep 4, 2026 | $1.36 | $1.385 | $1.355 | $1.37 | 80.36K |
| Sep 3, 2026 | $1.34 | $1.39 | $1.34 | $1.37 | 63.96K |
| Sep 2, 2026 | $1.47 | $1.47 | $1.35 | $1.35 | 236.56K |
| Sep 1, 2026 | $1.37 | $1.37 | $1.315 | $1.35 | 244.88K |
| Aug 31, 2026 | $1.34 | $1.41 | $1.3001 | $1.39 | 92.06K |
| Aug 28, 2026 | $1.36 | $1.36 | $1.3319 | $1.34 | 21.19K |
| Aug 27, 2026 | $1.37 | $1.37 | $1.35 | $1.36 | 43.66K |
| Aug 26, 2026 | $1.33 | $1.39 | $1.3201 | $1.37 | 143.21K |
| Aug 25, 2026 | $1.33 | $1.39 | $1.29 | $1.36 | 333.66K |
| Aug 24, 2026 | $1.29 | $1.35 | $1.29 | $1.33 | 181.44K |
| Aug 21, 2026 | $1.33 | $1.37 | $1.26 | $1.30 | 634.84K |
| Aug 20, 2026 | $1.2984 | $1.35 | $1.27 | $1.35 | 291.53K |
| Aug 19, 2026 | $1.36 | $1.375 | $1.295 | $1.33 | 351.71K |
| Aug 18, 2026 | $1.34 | $1.40 | $1.295 | $1.37 | 229.76K |
| Aug 17, 2026 | $1.35 | $1.40 | $1.30 | $1.36 | 159.35K |
The latest Smart Investors Daily articles mentioning WALD.
WALD research
Company profile and research snapshot.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 2, 2026 | Canaccord Genuity | Buy | — |
| Mar 16, 2026 | Telsey Advisory Group | Market Perform | — |
| Mar 16, 2026 | Canaccord Genuity | Buy | — |
| Nov 25, 2025 | Canaccord Genuity | Buy | — |
| Nov 25, 2025 | Telsey Advisory Group | Market Perform | — |
No generated briefing is available yet.
Benzinga · Jun 15, 2026
Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration ("FDA") has approved Obagi® saypha®
Benzinga · Jun 2, 2026
Canaccord Genuity analyst Susan Anderson maintains Waldencast (NASDAQ:WALD) with a Buy and raises the price target from $2 to $3.
Benzinga · Jun 1, 2026
Benzinga · Jun 1, 2026
Waldencast plc (NASDAQ:WALD) ("Waldencast" or "the Company") today announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare and aesthetics business ("Obagi Medical") to
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning WALD.
No results
No recent SID articles mention WALD.
